Related Experiment Videos
Induction of apoptosis by estramustine phosphate mediated by phosphorylation of bcl-2
D Yoshida1, M Noha, K Watanabe
1Department of Neurosurgery, Nippon Medical School, Tokyo, Japan. dyoshida@nms.ac.jp
Abstract:
Estramustine phosphate (EMP) is an anti-microtubule agent that induces apoptosis of glioma cells. We investigated whether EMP caused apoptosis through the alkylating effect of its nitrogen mustard component or by phosphorylation of bcl-2 like other anti-microtubule agents in normal human astrocyte and human malignant glioma cell lines. Apoptosis was seen in glioma cells treated either with nitrogen mustard or EMP and expression of bcl-2 mRNA was not changed by exposure to the drug. An immunoprecipitation study only found phosphorylation bcl-2 in glioma cells exposed to EMP and not in cells exposed to nitrogen mustard. These results indicate that induction of apoptosis in glioma cells by EMP is mediated by phosphorylation of bcl-2.
Insights
Estramustine phosphate (EMP) induces glioma cell death by phosphorylating bcl-2, not through alkylation. This mechanism, distinct from its nitrogen mustard component, offers new insights into glioma apoptosis.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Estramustine phosphate (EMP) is an established anti-microtubule agent used in cancer therapy.
- Glioma cells are susceptible to apoptosis induced by various chemotherapeutic agents.
- The precise mechanism of EMP-induced apoptosis in glioma, particularly the role of bcl-2, requires elucidation.
Purpose of the Study:
- To determine if estramustine phosphate (EMP)-induced apoptosis in glioma cells is mediated by its alkylating nitrogen mustard component or by bcl-2 phosphorylation.
- To investigate the effect of EMP and its nitrogen mustard component on bcl-2 mRNA expression and bcl-2 phosphorylation in glioma cells.
- To compare the apoptotic pathways activated by EMP and nitrogen mustard in normal human astrocytes and human malignant glioma cell lines.
Main Methods:
- Cell culture of normal human astrocytes and human malignant glioma cell lines.
- Treatment of cell lines with estramustine phosphate (EMP) and nitrogen mustard.
- Assessment of apoptosis using relevant assays.
- Analysis of bcl-2 mRNA expression via RT-PCR or similar techniques.
- Immunoprecipitation assays to detect bcl-2 phosphorylation.
Main Results:
- Apoptosis was observed in glioma cells treated with both nitrogen mustard and EMP.
- No significant change in bcl-2 mRNA expression was detected following exposure to either EMP or nitrogen mustard.
- Phosphorylation of bcl-2 was specifically identified in glioma cells treated with EMP, but not in those treated with nitrogen mustard.
Conclusions:
- Estramustine phosphate (EMP) induces apoptosis in glioma cells primarily through the phosphorylation of bcl-2.
- The alkylating effect of the nitrogen mustard component of EMP does not appear to be the primary driver of apoptosis in this context.
- These findings highlight a specific molecular mechanism for EMP's efficacy against glioma, suggesting targeted therapeutic strategies.